Hikma Pharmaceuticals has appointed Kristy Ronco as executive VP of Sales and Marketing for its Generics Division.
Ronco will be responsible for leading generics’ retail sales, addiction therapy sales and branded sales teams. She will also oversee marketing, pricing, forecasting and analytics.
“Kristy is a talented leader with significant pharmaceutical industry experience across sales, marketing, operations, market analysis, contracts and pricing, and we are delighted she is joining our team,” said Brian Hoffmann, president of Hikma’s Generics Division.
Ronco joins Hikma after 11 years at Zydus Pharmaceuticals where she was most recently Senior VP, Sales and Marketing. Earlier in her career, she held successive positions of increasing responsibility in marketing, contracts, pricing and market analysis at TEVA, Sandoz, Aventis and Johnson & Johnson.
Ronco is also a registered nurse with extensive clinical patient-care experience across a range of medical disciplines and specialties.
"I am thrilled to be joining Hikma’s Generics business and look forward to helping the company fulfill its vital mission of producing and distributing high-quality generic medicines that each day put better health within reach of millions of people,” said Ronco.
